Pädiatrische Neurochemie > Publikationen
Kohlschütter, A., A. Bley, K. Brockmann, J. Gartner, I. Krageloh-Mann, A. Rolfs and L. Schols (2010). Leukodystrophies and other genetic metabolic leukoencephalopathies in children and adults. Brain Dev 32(1): 82-89.
Lebrun, A. H., S. Storch, F. Ruschendorf, M. L. Schmiedt, A. Kyttala, S. E. Mole, C. Kitzmuller, K. Saar, L. D. Mewasingh, V. Boda, A. Kohlschutter, K. Ullrich, T. Braulke and A. Schulz (2009). Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship. Hum Mutat 30(5): E651-61.
Eichler, F., W. Grodd, E. Grant, M. Sessa, A. Biffi, A. Bley, A. Kohlschuetter, D. J. Loes and I. Kraegeloh-Mann (2009). Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. AJNR Am J Neuroradiol 30(10): 1893-7.
Henneke, M., S. Diekmann, A. Ohlenbusch, J. Kaiser, V. Engelbrecht, A. Kohlschutter, R. Kratzner, M. Madruga-Garrido, M. Mayer, L. Opitz, D. Rodriguez, F. Ruschendorf, J. Schumacher, H. Thiele, S. Thoms, R. Steinfeld, P. Nurnberg and J. Gartner (2009). RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection. Nat Genet 41(7): 773-5.
Kohlschutter, A. and A. Schulz (2009). Towards understanding the neuronal ceroid lipofuscinoses. Brain Dev 31(7): 499-502.
Sarpong, A., G. Schottmann, K. Ruther, G. Stoltenburg, A. Kohlschutter, C. Hubner and M. Schuelke (2009). Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X). Clin Genet 76(1): 38-45.
Kohlschütter, A. and B. Plecko (2009). Neurometabolic disorders and epilepsy. Advanced Therapy in Epilepsy. J. W. Wheless, L. J. Willmore and R. A. Brumback. Hamilton, BC Decker Inc: 92-98.
Kohlschütter, A. (2009). Ataxia due to vitamin E deficiency. Encyclopedia of Molecular Mechanisms of Disease. F. Lang. Heidelberg, Springer: 165-166.
Kohlschütter, A. (2009). Refsum disease. Encyclopedia of Molecular Mechanisms of Disease. F. Lang. Heidelberg, Springer: 1812-1813.
Kohlschütter, A. (2009). Neuronale Ceroid-Lipofuszinosen. Neuropädiatrische Therapie. R. Korinthenberg, C. P. Panteliadis and C. Hagel. München, Elsevier: 104-107.
Kohlschütter, A. (2009). Metachromatische Leukodystrophie (MLD). Neuropädiatrische Therapie. R. Korinthenberg, C. P. Panteliadis and C. Hagel. München, Elsevier: 102-104.
Charnas, L., F. Eichler, A. Kohlschuetter, J. Tolar and P. J. Orchard (2008). Reply to: Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica 2008; 93:e11-13. Haematologica 93(5): e47; author reply e48.
Kohlschütter, A. (2007). Stoffwechselscreening. Untersuchung von Neugeborenen auf endokrine und metabolische Krankheiten. Pädiatrie, Grundlagen und Praxis. M. Lentze, J. Schaub, F. J. Schulte and J. Spranger. Berlin, Springer: 73-76.
Kohlschütter, A. (2007). Neurolipidosen. Pädiatrie, Grundlagen und Praxis. M. Lentze, J. Schaub, F. J. Schulte and J. Spranger. Berlin, Springer: 286-298.
Kohlschütter, A. (2007). Mastering the Dilemma of Rare Diseases. Neuropediatrics 38: 1.
Kohlschuetter, A. (2007). Neuronal Ceroid-Lipofuscinoses (NCL): Clinical Overview and Diagnostic Approach. Brain and retina in degenerative diseases of childhood. B. Schmitt, A. Kohlschuetter, B. A. Neubauer and B. Plecko-Starting. Heilbronn, SHS International: 111-121.
Kohlschütter, A., J. Gärtner, P. Huppke, J. Klepper, B. Plecko, J. Seeger and N. Wolf (2007) "Diagnostisches Vorgehen bei Verdacht auf neurodegenerative oder neurometabolische Krankheit." Leitlinien der Gesellschaft für Neuropädiatrie, DOI: www.uni-duesseldorf.de/WWW/AWMF/ll/022-018.htm
Gorg, M., W. Wilck, B. Granitzny, A. Suerken, Z. Lukacs, X. Ding, M. Schulte-Markwort and A. Kohlschutter (2007). Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation: a 13-year follow-up. J Child Neurol 22(9): 1139-42.
Kohlschuetter, A. (2007). Demenz bei stoffwechselkranken Jugendlichen. Deutsche Behinderten-Zeitschrift 44(4): 9-11.
Schossig, A., N. Wolf, M. Koch, T. Bast, G. Hoffmann, J. Zschocke and A. Kohlschütter (2007). Epileptische Enzephalopathie und Zahnschmelzdefekt (Kohlschütter-Tönz-Syndrom): drei Fallberichte und Literaturübersicht. Med Genetik 19(4): 422-426.
Pohl, S., H. M. Mitchison, A. Kohlschutter, O. van Diggelen, T. Braulke and S. Storch (2007). Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue. J Neurochem 103(6): 2177-88.
Gartner, J., A. Kohlschutter and V. Gieselmann (2007). Netzwerkprojekte für die Erforschung von Leukodystrophien, einer Gruppe seltener Erkrankungen der weißen Substanz des Nervensystems Bundesgesundheitsblatt 50(12): 1531-40.
Ruther, K., A. Gal and A. Kohlschutter (2006). [The role of the ophthalmologist in the management of juvenile neuronal ceroid lipofuscinosis]. Klin Monatsbl Augenheilkd 223(6): 542-4.
Neubauer, B. A., I. Stefanova, C. A. Hubner, E. Neumaier-Probst, J. Bohl, H. C. Oppermann, H. Sto, A. Hahn, U. Stephani, A. Kohlschutter and A. Gal (2006). A new type of leukoencephalopathy with metaphyseal chondrodysplasia maps to Xq25-q27. Neurology 67(4): 587-91.
Williams, R. E., L. Aberg, T. Autti, H. H. Goebel, A. Kohlschutter and T. Lonnqvist (2006). Diagnosis of the neuronal ceroid lipofuscinoses: an update. Biochim Biophys Acta 1762(10): 865-72.
Haberlandt, E., C. Svejda, S. Felber, S. Baumgartner, B. Gunther, G. Utermann and D. Kotzot (2006). Yellow teeth, seizures, and mental retardation: a less severe case of Kohlschutter-Tonz syndrome. Am J Med Genet A 140(3): 281-3.
Ding, X. Q., M. Goerg, B. Eckert, A. Ohlenbusch, A. Kohlschuetter, J. Gaertner and H. Zeumer (2006). Rapidly progressive vanishing white matter disease in a child with previously inconspicuous brain MRI. Neuropediatrics 37(4): 253-6.
Steinfeld, R., A. Kohlschütter and J. Gärtner (2006). Funktionelle Konsequenzen und klinische Bedeutung unterschiedlicher Mutationen im CLN2-Gen, das mit der klassischen spätinfantilen neuronalen Ceroid-Lipofuszinose assoziiert ist. Aktuelle Neuropädiatrie 2005. D. Wenzel and R. Trollmann. Nürnberg, Novartis Pharma Verlag: 282-287.
Hubner, C. A., U. Orth, A. Senning, C. Steglich, A. Kohlschutter, R. Korinthenberg and A. Gal (2005). Seventeen novel PLP1 mutations in patients with Pelizaeus-Merzbacher disease. Hum Mutat 25(3): 321-2.
Ohlenbusch, A., M. Henneke, K. Brockmann, M. Goerg, F. Hanefeld, A. Kohlschutter and J. Gartner (2005). Identification of ten novel mutations in patients with eIF2B-related disorders. Hum Mutat 25(4): 411.
Santer, R., J. Rischewski, M. von Weihe, M. Niederhaus, S. Schneppenheim, K. Baerlocher, A. Kohlschutter, A. Muntau, H. G. Posselt, B. Steinmann and R. Schneppenheim (2005). The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. Hum Mutat 25(6): 594.
Henneke, M., N. Preuss, V. Engelbrecht, F. Aksu, E. Bertini, G. Bibat, K. Brockmann, C. Hubner, M. Mayer, V. Mejaski-Bosnjak, S. Naidu, E. Neumaier-Probst, D. Rodriguez, W. Weisz, A. Kohlschutter and J. Gartner (2005). Cystic leukoencephalopathy without megalencephaly: a distinct disease entity in 15 children. Neurology 64(8): 1411-6.
Lukacs, Z., A. Dietrich, R. Ganschow, A. Kohlschutter and R. Kruithof (2005). Simultaneous determination of HIV antibodies, hepatitis C antibodies, and hepatitis B antigens in dried blood spots--a feasibility study using a multi-analyte immunoassay. Clin Chem Lab Med 43(2): 141-5.
Donnai, D., P. I. Tomlin and R. M. Winter (2005). Kohlschutter syndrome in siblings. Clin Dysmorphol 14(3): 123-126.
Siintola, E., M. Topcu, A. Kohlschutter, T. Salonen, T. Joensuu, A. K. Anttonen and A. E. Lehesjoki (2005). Two novel CLN6 mutations in variant late-infantile neuronal ceroid lipofuscinosis patients of Turkish origin. Clin Genet 68(2): 167-73.
Kohlschütter, A., H. Goebel, A. Schulz and Z. Lukacs (2005). Die neuronalen Ceroid-Lipofuszinosen (NCL-Krankheiten) - Demenzerkrankungen bei Kindern und Jugendlichen. Dtsch Aerztebl 102(5): A 284-288.
Lukacs, Z., A. Keil, A. Kohlschutter, M. Beck and E. Mengel (2005). The ratio of alpha-galactosidase to beta-glucuronidase activities in dried blood for the identification of female Fabry disease patients. J Inherit Metab Dis 28(5): 803-5.
Schulz, A., S. Dhar, S. Rylova, G. Dbaibi, J. Alroy, C. Hagel, I. Artacho, A. Kohlschütter, S. Lin and R. Boustany (2005). Störung der Zelladhäsion und Apoptose bei einer neuen Variante der neuronalen Ceroid-Lipofuszinose, CLN9. Neuropädiatrie in Klinik und Praxis 4(4): 128-134.
Wenner, K. A., J. P. Vieira Pinheiro, G. Escherich, R. Wessalowski, N. Jorch, J. Wolff, M. Stehn, A. Kohlschutter, J. Boos and G. E. Janka-Schaub (2005). Asparagine Concentration in Plasma After 2 500 IU/m(2) PEG-Asparaginase i.v. in Children With Acute Lymphoblastic Leukemia. Klin Padiatr 217(6): 321-6.
Baehner, F., C. Schmiedeskamp, F. Krummenauer, E. Miebach, M. Bajbouj, C. Whybra, A. Kohlschutter, C. Kampmann and M. Beck (2005). Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 28(6): 1011-7.
van den Bussche, H., S. Anders, M. Ehrhardt, T. Gottsche, B. Huneke, A. Kohlschutter, R. Kothe, O. Kuhnigk, K. Neuber, M. Rijntjes, C. Quellmann and S. Harendza (2005). [Is a reformation of the medical training worthwhile? The quality of the Hamburg curriculum under the old and the new board certification law]. Z Arztl Fortbild Qualitatssich 99(7): 419-23.
Tsiakas, K., R. Steinfeld, S. Storch, J. Ezaki, Z. Lukacs, E. Kominami, A. Kohlschutter, K. Ullrich and T. Braulke (2004). Mutation of the glycosylated asparagine residue 286 in human CLN2 protein results in loss of enzymatic activity. Glycobiology.
Klepper, J., S. Diefenbach, A. Kohlschutter and T. Voit (2004). Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. Prostaglandins Leukot Essent Fatty Acids 70(3): 321-7.
Kohlschütter, A. and H. H. Goebel (2004). Neuronale Ceroid-Lipofuszinosen. Stoffwechselkrankheiten. G. F. Hoffmann and A. Grau. Stuttgart, Thieme.
Gärtner, J. and A. Kohlschütter (2004). Leukodystrophien. Stoffwechselkrankheiten. G. F. Hoffmann and A. Grau. Stuttgart, Thieme: 81-89.
Heine, C., B. Koch, S. Storch, A. Kohlschutter, D. N. Palmer and T. Braulke (2004). Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A. J Biol Chem 279(21): 22347-52.
Steinfeld, R., H. B. Steinke, D. Isbrandt, A. Kohlschutter and J. Gartner (2004). Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes. Hum Mol Genet.
Ding, X. Q., T. Kucinski, O. Wittkugel, E. Goebell, U. Grzyska, M. Gorg, A. Kohlschutter and H. Zeumer (2004). Normal brain maturation characterized with age-related T2 relaxation times: an attempt to develop a quantitative imaging measure for clinical use. Invest Radiol 39(12): 740-6.
Schulz, A., S. Dhar, S. Rylova, G. Dbaibo, J. Alroy, C. Hagel, I. Artacho, A. Kohlschutter, S. Lin and R. M. Boustany (2004). Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant. Ann Neurol 56(3): 342-50.
Steinfeld, R., A. Kohlschutter, K. Ullrich and Z. Lukacs (2004). Efficiency of long-term tetrahydrobiopterin monotherapy in phenylketonuria. J Inherit Metab Dis 27(4): 449-53.
Ding, X.-Q., Z. Lukacs, T. Kucinski, O. Wittkugel, D. Kilian, W. Weisz, A. Kohlschütter and H. Zeumer (2004). MRI and MRS findings in a patient with infantile neuronal ceroid lipofuscinosis. Klin Neuroradiol 4: 261-264.
Harendza, S., S. Anders, M. Ehrhardt, T. Göttsche, W. Harren, B. Hüneke, M. Kellner, A. Kohlschütter, R. Kothe, K. Neuber, C. Quellmann, M. Rijntjes, H. van den Bussche and A. Stahl (2004). KliniCuM: Das neue klinische Curriculum am UKE. Hamb Ärztebl(4): 298-299.
Rubie, C., P. Lichtner, J. Gartner, M. Siekiera, G. Uziel, B. Kohlmann, A. Kohlschutter, T. Meitinger, G. Stober and T. Bettecken (2003). Sequence diversity of KIAA0027/MLC1: are megalencephalic leukoencephalopathy and schizophrenia allelic disorders? Hum Mutat 21(1): 45-52.
Wiedemann, M., A. Kontush, B. Finckh, H. H. Hellwege and A. Kohlschutter (2003). Neonatal Blood Plasma Is Less Susceptible to Oxidation Than Adult Plasma Owing to Its Higher Content of Bilirubin and Lower Content of Oxidizable Fatty Acids. Pediatr Res.
Lukacs, Z., P. Santavuori, A. Keil, R. Steinfeld and A. Kohlschutter (2003). Rapid and simple assay for the determination of tripeptidyl peptidase and palmitoyl protein thioesterase activities in dried blood spots. Clin Chem 49(3): 509-11.
Lukacs, Z., C. Mordac, A. Kohlschutter and R. Kruithof (2003). Use of microsphere immunoassay for simplified multianalyte screening of thyrotropin and thyroxine in dried blood spots from newborns. Clin Chem 49(2): 335-6; author reply 336.
Steinfeld, R., A. Kohlschutter, K. Ullrich and Z. Lukacs (2003). A hypothesis on the biochemical mechanism of BH(4)-responsiveness in phenylalanine hydroxylase deficiency. Amino Acids 25(1): 63-8.
Thiel, C., M. Schwarz, J. Peng, M. Grzmil, M. Hasilik, T. Braulke, A. Kohlschutter, K. von Figura, L. Lehle and C. Korner (2003). A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J Biol Chem 278(25): 22498-505.
Ferdinandusse, S., B. Finckh, Y. C. de Hingh, L. E. Stroomer, S. Denis, A. Kohlschutter and R. J. Wanders (2003). Evidence for increased oxidative stress in peroxisomal D-bifunctional protein deficiency. Mol Genet Metab 79(4): 281-7.
Lukacs, Z., J. Gieseking, B. Finckh and A. Kohlschutter (2003). Membrane oxidation assay--a novel lipoxygenase-based evaluation of membrane oxidizability. Free Radic Res 37(4): 413-7.
Kluge, S., P. Kuhnelt, A. Block, M. Merkel, A. Gocht, Z. Lukacs, A. Kohlschutter and G. Kreymann (2003). A young woman with persistent hypoglycemia, rhabdomyolysis, and coma: recognizing fatty acid oxidation defects in adults. Crit Care Med 31(4): 1273-6.
Neumaier Probst, E., C. Hagel, V. Weisz, S. Nagel, O. Wittkugel, H. Zeumer and A. Kohlschutter (2003). Atypical focal MRI lesions in a case of juvenile Alexander's disease. Ann Neurol 53(1): 118-20.
Kohlschütter, A. (2003). Angeborene Störungen des Fettsäurenstoffwechsels - Klinik und Behandlung. Diät bei angeborenen Fettstoffwechselstörungen und ketogene Diät. K. Dokoupil and E. Riemann. Heilbronn, SHS Verlagsgesellschaft: 49-60.
Lukacs, Z., A. Keil, V. Peters, A. Kohlschutter, G. F. Hoffmann, M. Cantz and J. Kopitz (2003). Towards quality assurance in the determination of lysosomal enzymes: a two-centre study. J Inherit Metab Dis 26(6): 571-81.
Horstmann, M., E. Neumaier-Probst, Z. Lukacs, R. Steinfeld, K. Ullrich and A. Kohlschutter (2003). Infantile cobalamin deficiency with cerebral lactate accumulation and sustained choline depletion. Neuropediatrics 34(5): 261-4.
Heine, C., J. Tyynela, J. D. Cooper, D. N. Palmer, M. Elleder, A. Kohlschutter and T. Braulke (2003). Enhanced expression of manganese-dependent superoxide dismutase in human and sheep CLN6 tissues. Biochem J 376(Pt 2): 369-76.
Flierl-Hecht, A., M. Pfafflin, T. W. May, S. Kohlschutter, B. Hensel and H. Stefan (2003). [Is epilepsy in the elderly overlooked? An investigation in a home for the aged]. Nervenarzt 74(8): 691-8.
Teixeira, C. A., J. Espinola, L. Huo, J. Kohlschutter, D. A. Persaud Sawin, B. Minassian, C. J. Bessa, A. Guimaraes, D. A. Stephan, M. C. Sa Miranda, M. E. MacDonald, M. G. Ribeiro and R. M. Boustany (2003). Novel mutations in the CLN6 gene causing a variant late infantile neuronal ceroid lipofuscinosis. Hum Mutat 21(5): 502-8.
Stuerenburg, H.-H., B. Stangneth, A. Kohlschütter and B. Finckh (2003). Influence of diagnostic categories, age, and gender on antioxidative defense and lipid peroxidation in skeletal muscle of patients with neuromuscular diseases. J Amer Aging Assoc 26: 39-46
Probst, E. N., C. Hagel, V. Weisz, S. Nagel, O. Wittkugel, H. Zeumer and A. Kohlschutter (2003). Atypical focal MRI lesions in a case of juvenile Alexander's disease. Ann Neurol 53(1): 118-20.
Kohlschütter, A. (2002). Metabolische Ursachen geistiger Behinderung. Aktuelle Neuropädiatrie 2001. F. Aksu. Nürnberg, Novartis.
Kohlschütter, A. (2002). Neurodegenerative Erkrankungen. Neuropädiatrie - Diagnostik und Therapie neurologischer Erkrankungen im Kindes- und Jugendalter. F. Aksu. Bremen, UNI-MED-Verlag ISBN 3-89599-608-4: 164-174.
Steinfeld, R., A. Kohlschutter, J. Zschocke, M. Lindner, K. Ullrich and Z. Lukacs (2002). Tetrahydrobiopterin monotherapy for phenylketonuria patients with common mild mutations. Eur J Pediatr 161(7): 403-5.
Steinfeld, R., P. Heim, H. Von Gregory, K. Meyer, K. Ullrich, H. H. Goebel and A. Kohlschutter (2002). Late infantile neuronal ceroid lipofuscinosis: Quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet 112(4): 347-54.
Wittenstein, B., M. Klein, B. Finckh, K. Ullrich and A. Kohlschutter (2002). Radical trapping in glycogen storage disease 1a. Eur J Pediatr 161 Suppl 1: S70-4.
Wittenstein, B., M. Klein, B. Finckh, K. Ullrich and A. Kohlschutter (2002). Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med 33(1): 103-10.
Kohlschütter, A. (2001). Juvenile neuronale Ceroidlipofuszinose (juvenile NCL): medizinische Gesichtspunkte. NCL: Zur Lebenssituation von blinden Kindern und Heranwachsenden mit einer unheilbaren Abbauerkrankung. H. Schlegel. Hannover, Verein zur Förderung der Blindenbildung. 3: 29-42.
Gong, Y., R. B. Slee, N. Fukai, G. Rawadi, S. Roman-Roman, A. M. Reginato, H. Wang, T. Cundy, F. H. Glorieux, D. Lev, M. Zacharin, K. Oexle, J. Marcelino, W. Suwairi, S. Heeger, G. Sabatakos, S. Apte, W. N. Adkins, J. Allgrove, M. Arslan-Kirchner, J. A. Batch, P. Beighton, G. C. Black, R. G. Boles, L. M. Boon, C. Borrone, H. G. Brunner, G. F. Carle, B. Dallapiccola, A. De Paepe, B. Floege, M. L. Halfhide, B. Hall, R. C. Hennekam, T. Hirose, A. Jans, H. Juppner, C. A. Kim, K. Keppler-Noreuil, A. Kohlschuetter, D. LaCombe, M. Lambert, E. Lemyre, T. Letteboer, L. Peltonen, R. S. Ramesar, M. Romanengo, H. Somer, E. Steichen-Gersdorf, B. Steinmann, B. Sullivan, A. Superti-Furga, W. Swoboda, M. J. van den Boogaard, W. Van Hul, M. Vikkula, M. Votruba, B. Zabel, T. Garcia, R. Baron, B. R. Olsen and M. L. Warman (2001). LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107(4): 513-23.
Das, A. M., R. von Harlem, M. Feist, T. Lucke and A. Kohlschutter (2001). Altered levels of high-energy phosphate compounds in fibroblasts from different forms of neuronal ceroid lipofuscinoses: further evidence for mitochondrial involvement. Europ J Paediatr Neurol 5 Suppl A: 143-6.
Oexle, K. and A. Kohlschutter (2001). Cause of progression in Duchenne muscular dystrophy: impaired differentiation more probable than replicative aging. Neuropediatrics 32(3): 123-9.
Heitzer, T., B. Finckh, S. Albers, K. Krohn, A. Kohlschutter and T. Meinertz (2001). Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 31(1): 53-61.
Goebel, H. H. and A. Kohlschutter (2001). Dementia in the neuronal ceroid-lipofuscinoses. Adv Exp Med Biol 487: 211-7.
 |
Degenerative Gehirnerkrankungen |
